Sort
8,912 grants matching “sars cov 2”
Innate Control of Adaptive Immunity to SARS-CoV-2
$193,604Benjamin Goldman-Israelow · Yale University · K08 · FY2022 · AI
RAPID / SARS-CoV-2 host cell interactions: quantitative investigations via Scanning Helium-ion Microscopy
$193,590Leonard C Feldman · Rutgers University New Brunswick · · FY2021 · BIO
Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways
$193,438Jianming Qiu · University Of Kansas Medical Center · R21 · FY2022 · AI
Impact of Heterogeneous Airway Epithelial ACE2 Expression and Interferon Responses on SARS-CoV2 Infectivity and Replication
$193,352Jason S Debley · Seattle Children'S Hospital · K24 · FY2020 · AI
Impact of gestational SARS-CoV-2 and maternal inflammation on child growth and neurodevelopment in a malaria-endemic setting
$193,320Karen Blake Jacobson · Kaiser Foundation Research Institute · K23 · FY2023 · AI
Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
$193,320Arjun Rustagi · Stanford University · K08 · FY2023 · AI
Impact of gestational SARS-CoV-2 and maternal inflammation on child growth and neurodevelopment in a malaria-endemic setting
$193,320Karen Blake Jacobson · Kaiser Foundation Research Institute · K23 · FY2024 · AI
Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
$193,320Arjun Rustagi · Stanford University · K08 · FY2022 · AI
Impact of gestational SARS-CoV-2 and maternal inflammation on child growth and neurodevelopment in a malaria-endemic setting
$193,320Karen Blake Jacobson · Kaiser Foundation Research Institute · K23 · FY2025 · AI
RAPID: Determination of the cross-over frequency of SARS-CoV-2 for rapid identification concentration
$193,230Woo Jin Chang · University Of Wisconsin-Milwaukee · · FY2020 · BIO
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
$193,154Alicia M Pickrell · Virginia Polytechnic Inst And St Univ · R21 · FY2023 · AI
A novel model to study COVID-19 and Hypertension
$193,125Bina Joe · University Of Toledo Health Sci Campus · R21 · FY2022 · AI
Epitranscriptomic m6A profile of SARS-CoV-2-infected human lung epithelial cells
$193,125Li Wu · University Of Iowa · R21 · FY2021 · AI
Development and Evaluation of Novel Aptamer-based Therapeutics Targeting SARS-CoV-2 in a Physiologically-Relevant Model of Human Airway Epithelium
$193,125Jeffrey J Destefano · Univ Of Maryland, College Park · R21 · FY2022 · AI
Disparities in Cancer Outcomes from the COVID-19 Pandemic
$193,125Brian Robert Englum · University Of Maryland Baltimore · R21 · FY2024 · MD
Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections
$193,125Mary Ann Y Jabra-Rizk · University Of Maryland Baltimore · R21 · FY2023 · DE
SARS-CoV-2 immune responses in patients with lymphoma
$192,888Andres Chang · Emory University · K08 · FY2025 · AI
SARS-CoV-2 immune responses in patients with lymphoma
$192,888Andres Chang · Emory University · K08 · FY2024 · AI
flowBEAT: a multiparameter flow cytometry assay to discover longitudinal antibody responses associated with efficient recovery from COVID-19
$192,880Eliver Ghosn · Emory University · R21 · FY2023 · AI
NOX1 and NOX2 as Therapeutic Targets in Influenza
$192,808J. David Lambeth · Emory University · R21 · FY2012 · AI
Clinical Core
$192,789Asuncion Mejias · St. Jude Children'S Research Hospital · U19 · FY2025 · AI
Core D - Data Management and Bioinformatics Core
$192,750Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Viral Testing Core
$192,551Koen K Van Rompay · University Of California At Davis · U42 · FY2024 · OD
Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures
$192,509Arjun Rustagi · University Of California, San Francisco · K08 · FY2025 · AI
Priming and fusion activation of the SARS coronavirus spike glycoprotein
$192,500Gary R Whittaker · Cornell University · R21 · FY2009 · AI